STORM in the News

Optimum TV - Modifying RNA with small molecule drugs: a new approach to immunotherapy

Check out STORM CEO, Jerry McMahon, in the latest edition of Optimum TV where he discusses STORM's approach to cellular reprogramming through RNA modification.

Jerry highlights the founding of STORM Therapeutics, its technology and lead product STC-15, and more.